亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

嵌合抗原受体 CD19 T细胞 细胞因子释放综合征 医学 细胞因子 白血病 抗原 癌症研究 免疫学 药理学 持久性(不连续性) 免疫系统 工程类 岩土工程
作者
Sara Ghorashian,Anne Marijn Kramer,Shimobi Onuoha,Gary Wright,Jack Bartram,Rachael T. Richardson,Sarah J. Albon,Joan Casanovas-Company,Fernanda Castro,Bilyana Popova,Krystle Villanueva,Jenny Yeung,Winston Vetharoy,Aleks Guvenel,Patrycja Wawrzyniecka,Leila Mekkaoui,Gordon Weng-Kit Cheung,Danielle Pinner,Jan Chu,Giovanna Lucchini,Clóvis A. Silva,Oana Ciocârlie,Arina Lazareva,Sarah Inglott,Kimberly Gilmour,Gulrukh Ahsan,Mathieu Ferrari,Somayya Manzoor,Kim Champion,Tony Brooks,Andre Lopes,Allan Hackshaw,Farzin Farzaneh,Robert Chiesa,Kanchan Rao,Denise Bonney,Sujith Samarasinghe,Nicholas Goulden,Ajay Vora,Paul Veys,Rachael Hough,Robert Wynn,Martin Pulè,Persis Amrolia
出处
期刊:Nature Medicine [Springer Nature]
卷期号:25 (9): 1408-1414 被引量:449
标识
DOI:10.1038/s41591-019-0549-5
摘要

Chimeric antigen receptor (CAR)-modified T cells targeting CD19 demonstrate unparalleled responses in relapsed/refractory acute lymphoblastic leukemia (ALL)1-5, but toxicity, including cytokine-release syndrome (CRS) and neurotoxicity, limits broader application. Moreover, 40-60% of patients relapse owing to poor CAR T cell persistence or emergence of CD19- clones. Some factors, including the choice of single-chain spacer6 and extracellular7 and costimulatory domains8, have a profound effect on CAR T cell function and persistence. However, little is known about the impact of CAR binding affinity. There is evidence of a ceiling above which increased immunoreceptor affinity may adversely affect T cell responses9-11. We generated a novel CD19 CAR (CAT) with a lower affinity than FMC63, the high-affinity binder used in many clinical studies1-4. CAT CAR T cells showed increased proliferation and cytotoxicity in vitro and had enhanced proliferative and in vivo antitumor activity compared with FMC63 CAR T cells. In a clinical study (CARPALL, NCT02443831 ), 12/14 patients with relapsed/refractory pediatric B cell acute lymphoblastic leukemia treated with CAT CAR T cells achieved molecular remission. Persistence was demonstrated in 11 of 14 patients at last follow-up, with enhanced CAR T cell expansion compared with published data. Toxicity was low, with no severe CRS. One-year overall and event-free survival were 63% and 46%, respectively.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
20秒前
26秒前
Lucas应助Scrat采纳,获得10
31秒前
Olivia发布了新的文献求助30
1分钟前
1分钟前
小蘑菇应助帮帮我好吗采纳,获得10
1分钟前
1分钟前
zoelir729发布了新的文献求助10
1分钟前
2分钟前
2分钟前
传奇3应助帮帮我好吗采纳,获得10
2分钟前
2分钟前
2分钟前
3分钟前
Scrat发布了新的文献求助10
3分钟前
顾矜应助郑夏岚采纳,获得10
3分钟前
4分钟前
郑夏岚发布了新的文献求助10
4分钟前
4分钟前
郑夏岚完成签到,获得积分10
4分钟前
8R60d8应助科研通管家采纳,获得20
4分钟前
完美世界应助科研通管家采纳,获得10
4分钟前
8R60d8应助科研通管家采纳,获得20
4分钟前
4分钟前
小蘑菇应助zhouleiwang采纳,获得10
5分钟前
川藏客完成签到 ,获得积分10
5分钟前
帮帮我好吗完成签到,获得积分10
6分钟前
研友_R2D2发布了新的文献求助10
7分钟前
zsmj23完成签到 ,获得积分0
7分钟前
8分钟前
桓某人发布了新的文献求助10
8分钟前
科研小白书hz完成签到 ,获得积分10
9分钟前
俏皮马里奥完成签到 ,获得积分10
10分钟前
11分钟前
桓某人发布了新的文献求助10
11分钟前
桓某人完成签到,获得积分10
11分钟前
Scrat完成签到,获得积分10
11分钟前
SciGPT应助秋刀鱼不过期采纳,获得10
11分钟前
Chris完成签到 ,获得积分0
12分钟前
小石榴爸爸完成签到 ,获得积分10
12分钟前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137011
求助须知:如何正确求助?哪些是违规求助? 2787981
关于积分的说明 7784214
捐赠科研通 2444073
什么是DOI,文献DOI怎么找? 1299719
科研通“疑难数据库(出版商)”最低求助积分说明 625497
版权声明 600997